Aleksey Anatol'Yevich Khodakovskiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aleksey Anatol'Yevich Khodakovskiy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy Vladimirovich Evdokimov
M. Gorkiy Donetsk National Medical University
1 shared publication Igor' Igorevich Abramets
National Medical University named after M. Gorky of Ministry of Healthcare of Ukraine
1 shared publicationLeonid Borisovich Braverman
Vinnytsia regional psychoneurological hospital of Akkad. And. I. Yushchenko
1 shared publicationOl'Ga Vital'Yevna Khodakovskaya
Vinnytsa National Medical University named after N.I. Pirogov of Ministry of Healthcare of Ukraine
1 shared publicationRuslan Grigor'Yevich Red'Kin
National University of Pharmacy MPH of Ukraine
1 shared publication- Sergey Yur'YEvich Shtrygol'
National University of Pharmacy
1 shared publication
Latest Publications
- Open Access
- 15 March 2015
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 13 (1) , 56-61
Neurochemical mechanisms of the cerebroprotective action of spiro[indole-3,1'-pyrrol [3,4-с] pyrrol] derivative
The mechanisms of the neuroprotective effect of 3,2’-spiro-pyrrolo-2-оxindole derivative (code number R-86) were investigated in hippocampal sections of rats by measuring the amplitude of postsynaptic potentials in pyramidal neurons. In vitro R-86 reduced the responces to NMDA-receptors activation as well as hydrogen peroxide-induced injury, being not active in anoxia and neuroglycopenia. When systemically administered, R-86 exerted weak effect in anoxia and neuroglycopenia and decreased steroid-induced neurotoxicity.
- 15 March 2015
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 13 (1) , 56-61
Open AccessNeurochemical mechanisms of the cerebroprotective action of spiro[indole-3,1'-pyrrol [3,4-с] pyrrol] derivative
The mechanisms of the neuroprotective effect of 3,2’-spiro-pyrrolo-2-оxindole derivative (code number R-86) were investigated in hippocampal sections of rats by measuring the amplitude of postsynaptic potentials in pyramidal neurons. In vitro R-86 reduced the responces to NMDA-receptors activation as well as hydrogen peroxide-induced injury, being not active in anoxia and neuroglycopenia. When systemically administered, R-86 exerted weak effect in anoxia and neuroglycopenia and decreased steroid-induced neurotoxicity.